ALLK
Allakos, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website allakos.com
- Employees(FY) 123
- ISIN US01671P1003
Performance
+11.63%
1W
+37.14%
1M
+15.2%
3M
-19.55%
6M
-47.25%
YTD
-71.31%
1Y
Profile
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and/or eosinophilic duodenitis; a Phase II/III study for eosinophilic esophagitis; and a Phase II clinical study to atopic dermatitis and chronic spontaneous urticaria. It is also developing lirentelimab (AK002) for the treatment of mast cell gastrointestinal disease, chronic urticaria, severe allergic conjunctivitis, and indolent systemic mastocytosis; and AK006 to treat allergic and inflammatory diseases. In addition, Allakos Inc. is conducting preclinical studies for AK007, which polarizes tumor-associated myeloid cells and promotes anti-tumor immunity. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Technical Analysis of ALLK 2024-05-10
Overview:
In analyzing the technical indicators for ALLK over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysis:
...Recent News & Updates
- 2024-05-10 04:02
- 2024-05-09 10:56
ALLK Stock Earnings: Allakos Meets EPS for Q1 2024(Investorplace)
- 2024-05-09 04:02
- 2024-05-02 19:31
- 2024-04-08 18:31
3 Biotech Stocks to Dump Before They Go to Zero(Yahoo Finance)
- 2024-04-03 20:36
- 2024-03-15 17:31
- 2024-03-14 09:54
ALLK Stock Earnings: Allakos Misses EPS for Q4 2023(Investorplace)
- 2024-03-14 04:02
- 2024-02-25 18:02
- 2024-02-11 18:02
- 2024-01-17 20:35
- 2024-01-16 23:10
- 2024-01-15 22:36
Why Is Allakos (ALLK) Stock Down 57% Today?(Investorplace)
- 2024-01-15 20:40
- 2024-01-15 20:28
- 2024-01-15 18:27
- 2024-01-15 18:17
- 2024-01-15 18:02
- 2024-01-15 18:00
- 2024-01-15 16:09
- 2023-11-13 04:01
- 2023-11-13 03:02
- 2023-09-27 00:10
Why Shares of Allakos Are Up Wednesday(Yahoo Finance)
- 2023-08-30 04:05
Allakos Appoints Neil Graham to its Board of Directors(Yahoo Finance)
- 2023-08-09 04:02
- 2023-08-02 04:05
- 2023-08-01 20:20
- 2023-06-11 19:02
- 2023-06-04 19:02
Page 1 of 4
previousnext